Skip to main navigation
Skip to search
Skip to main content
Scholars @ UT Health San Antonio Home
Help & FAQ
Link opens in a new tab
English
Español
Search content at Scholars @ UT Health San Antonio
Home
Profiles
Research units
Publications
Datasets
GLP-1 Receptor Agonists: Practical Considerations for Clinical Practice
Curtis Triplitt
,
Carolina Solis-Herrera
Division of Diabetes
Division of Endocrinology
Research output
:
Contribution to journal
›
Article
›
peer-review
12
Link opens in a new tab
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'GLP-1 Receptor Agonists: Practical Considerations for Clinical Practice'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Medicine and Dentistry
Glucagon-Like Peptide-1 Agonist
100%
Inpatient
44%
Maturity Onset Diabetes of the Young
33%
Exenatide
33%
Therapeutic Procedure
33%
Glucose
22%
Glycemic Control
22%
Glycon
22%
Liraglutide
22%
Patient
22%
Health Outcomes
11%
Body Weight
11%
Combination Therapy
11%
Hypoglycemia
11%
Monotherapy
11%
Blood Pressure
11%
Cardiovascular Risk
11%
Adverse Event
11%
Individualization
11%
Postprandial Hyperglycemia
11%
Secretagogue
11%
Temefos
11%
Drug
11%
Chemotherapeutic Agent
11%
Marker
11%
Incidence
11%
Nursing and Health Professions
Glucagon Like Peptide 1 Receptor Agonist
100%
Non Insulin Dependent Diabetes Mellitus
33%
Insulin
33%
Exendin 4
33%
Glucose
22%
Clinical Practice
22%
Patient with Type 2 Diabetes
22%
Metformin
22%
Liraglutide
22%
Patient Education
11%
Cardiovascular Risk
11%
Monotherapy
11%
Glucose Blood Level
11%
Combination Therapy
11%
Adverse Event
11%
Body Weight
11%
Heart Rate
11%
Blood Pressure
11%
Individualization
11%
Drug
11%
Hypoglycemia
11%
Time
11%
Marker
11%
Incidence
11%
Body Weight Loss
11%
Temefos
11%